Needle-free transdermal delivery of lipid based ionic liquid mediated laminarin-loaded solid-in-oil nanodispersion for enhanced antibody response

Clicks: 3
ID: 318165
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #789 of 790 articles by views in phytochemistry letters

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 790 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Herein, a lipid-based ionic liquid-mediated laminarin-loaded solid-in-oil nanodispersion was successfully developed. The developed dispersion exhibited favorable biocompatibility in both in vitro and in vivo evaluations and showed significantly enhanced in vitro skin permeability. Notably, transdermal immunization with the nanodispersion elicits ovalbumin-specific antibody responses comparable to those achieved by subcutaneous injection of ovalbumin at an equivalent dose. These findings highlight the potential of laminarin-loaded nanodispersion as a promising platform for noninvasive, needle-free transdermal vaccination.
Reference Key
openalex_W7165516478 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Md Shahin Sarker, Yoshirou Kawaguchi, Rie Wakabayashi, Noriho Kamiya, Muhammad Moniruzzaman, Masahiro Goto
Journal phytochemistry letters
Year 2026
DOI
10.1093/chemle/upag127
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.